Russian scientific events 2024

February, 15
IV International Round Table

"Interaction of non-communicable and infectious diseases: impact on prognosis and quality of life of patients"

Moscow, Russia

March 19-24
XIII International Forum of Cardiologists and Therapists

Moscow, Russia

April 19-20

XI Educational Forum "Russian Days of the Heart"

St. Petersburg, Russia

April 26th

IV Interregional Scientific and Educational Conference of Therapists and Cardiologists of Siberia and the Far East

Omsk, Russia

May 23-24

XIV International Congress "Cardiology at the Crossroads of Sciences"

Tyumen, Russia

May 31 - June 1

Forum of Young Cardiologists

Krasnodar, Russia

September 26-28

Russian National Congress of Cardiology 2024

St. Petersburg, Russia

October 27-28

All-Russian Cardiology Conference "Traditions and Innovations in Cardiology"

Krasnoyarsk, Russia

Non-cardiac birth defects and long-term risk of cardiovascular hospitalisation Patients with heart defects are at risk of developing cardiovascular disease. Our objective was to determine if non-cardiac birth defects are associated with the risk of cardiovascular hospitalisation.

Urate in Atherosclerotic Plaques Boosts Risk for CV Events Patients with gout and hyperuricemia harboring cardiovascular (CV) monosodium urate (MSU) deposits in atherosclerotic plaques are at an increased risk for major adverse cardiovascular events (MACE).

Don't Overlook Underlying CV Risks In RA Treatmen Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists should consider a patient with RA's cardiovascular disease (CVD) status before deciding on RA treatments, a researcher of cardiometabolic disorders advised.

Microvascular disease and arrhythmias: a renewed focus on the myocardial microvasculature? Arrhythmias, and in particular atrial fibrillation (AF), are one of the greatest healthcare challenges of our time. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction.

In Angina, Gene Therapy Coaxes Heart Vessel Growth An experimental new gene therapy has specialists questioning whether heart vessel growth to restore blood flow could actually be possible in refractory angina after bypass surgery.

CARDIOPROGRESS
Foundation for the advancement of cardiology